None listed
Conditions
Brief summary
Each year over 10 000 children attend Princess Margaret Hospital for Children (PMH) to have surgery under general anaesthesia, with many more children attending other hospitals at a state and national level. Respiratory complications are the most frequent problem under general anaesthesia, particularly in young children. Over one quarter of children visiting PMH for surgery have asthma or related breathing difficulties. These complications may have an impact on surgical outcomes, may lead to delays and cancelled surgeries as well as unplanned admissions to specialised wards. These respiratory complications can be minimised if children at risk are correctly identified preoperatively. Currently, anaesthetists rely on clinical histories to assess this risk. Symptoms such as asthma, wheezing, hay fever and a family history of allergies and asthma amongst others are all associated with a higher risk of respiratory complications under general anaesthesia. Over a series of studies, we have observed that children with active respiratory symptoms such as current asthma, wheeze or persistent dry nocturnal cough experience significantly more respiratory complications compared to children with other known risk factors (such as family history of asthma) or no risk factors. Our data suggests that these children have increased airway inflammation and lower lung function; in a previous study, we observed that 7 out of 10 children with active respiratory symptoms who had airway inflammation experienced respiratory complications during surgery. The use of new screening techniques that allow assessment of the risk for respiratory complications by measuring airway inflammation and changes in lung function would help anaesthetists to better assess this risk. This would then allow the anaesthetist to tailor a personalised anaesthesia management to minimise the risk for these complications. This pilot study aims to assess the feasibility of an innovative personalised approach, easily applicable to young children to significantly improve the prediction of respiratory complications prior to surgery. Males and females aged 4 to 10 years of age will be recruited after voluntary informed consent and will complete two tests prior to their surgery. Tests include measuring airway inflammation using the exhaled nitric oxide test and measuring lung mechanics using the forced oscillation technique. Strong evidence of successful use of these screening techniques will pave the way to dramatically change surgical and anaesthetic risk management prior to surgery and lead to improved health outcomes for children, their families and the broader health-care system.
Interventions
Following voluntary written informed consent by a parent or legal guardian and child assent, measurements of exhaled nitric oxide and forced oscillation lung function testing will be carried out on the ward prior to the child being taken to theatre. Techniques: Exhaled nitric oxide (eNO): Exhaled NO will be measured using a Niox Vero (Aerocrine, Sweden). Briefly, the child will place the measurement end of the device to his/her lip and perform a normal but continuous exhalation. The device will then measure the level of eNO and display the corresponding value on the screen attached. Either three acceptable measurements within 10% of each other or two measurements within 5% of each other will be made according to international guidelines of the European Respiratory Society (ERS) and the American Thoracic Society (ATS). These measurements are used regularly by our research group. Forced Oscillation Technique The Forced Oscillation Technique (FOT) will be used to provide information regarding the resistance of the airways and the reactance (stiffness) of the lung tissues. This quick and easy test during normal tidal breathing does not require any active effort by the child and is completed in less than 5 minutes. FOT is a clinically validated technique routinely used by our group. Briefly, the FOT system superimposes a small amplitude sound wave within a given range of frequencies over the tidal breathing of the child (Tremoflo (registered trademark), THORASYS Thoracic Medical Systems Inc., Canada). The participants will wear a nose clip and perform tidal breathing via a mouthpiece with cheek supported. Three to five measurements within 10% of each other are required according to the international guidelines from the European Respiratory Society and American Thoracic Society. Both measurements will be completed with participants on the day of surgery, on the ward prior to going to theatre. Appropriately trained and delegated researchers will perform the measurements. Measurements should take less than 30 minutes with each participant.
Sponsors
Eligibility
Inclusion criteria
Children, aged 4 to 10 years of age, male and female, undergoing elective surgery under general anaesthesia at our site. Test group: 1 or more respiratory risk factors: *Wheeze (more than or equal to 3 times) over past year *Recurrent respiratory symptoms during exercise in the past year *Persistent dry cough in last 12 months Control group: *No doctor diagnosed active respiratory symptoms as listed in test group *Can have family history of: *Hay fever *Asthma *Eczema
Exclusion criteria
Exclusion criteria: *Cystic Fibrosis, bronchiectasis (doctor diagnosed conditions) *Cardiac or Thoracic surgery *Doctor diagnosed cardiac diseases *Known major Syndromes *Use of ketamine or midazolam premedication *Contraindication to the use of sevoflurane *Less than 32 weeks gestational age *Recent cold